Methylprednisolone Tablets USP recall: Labeling Error
Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03
Why was Methylprednisolone Tablets USP recalled?
Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022
- Product
- Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03
- Recalling firm
- Jubilant Cadista Pharmaceuticals, Inc.
- Quantity
- 635,400 cartons
- Distribution
- USA nationwide, including Puerto Rico.
- Recall date
- March 10, 2021
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)